Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Medline ® Abstract for Reference 47

of 'Treatment of community-acquired pneumonia in adults who require hospitalization'

US Food and Drug Administration (FDA). FDA drug safety communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new boxed warning. http://www.fda.gov/Drugs/DrugSafety/ucm369580.htm (Accessed on October 09, 2013).
no abstract available